Drug discovery and development – Page 37
-
OpinionProtecting patients at all costs
Suffering stagnant output, and beset by patent expiries and spiralling costs, drug discovery is in poor health. Simon Campbell prescribes a remedy
-
OpinionMonopoly money
Dean Baker says it’s time to start talking seriously about the way in which pharma is funded
-
FeatureFast, flexible and flourishing
Paul Workman’s experiences in big pharma, academia and biotech gave him the tools to develop new drugs and spin out successful companies. Sarah Houlton profiles the 2012 Chemistry World entrepreneur of the year
-
-
FeatureDrawing on drugs to kick the habit
While pharma companies stand accused of giving up on drugs to help people stop smoking, tobacco firms are looking at controversial nicotine replacement products. Anthony King surveys an area that is problematic on all sides.
-
News€224 million EU antibiotics initiative launched
The project will bring together the pharmaceutical industry and academia, but some institutes have reservations
-
OpinionPeace, love and understanding
Chemists and biologists often view the process of drug discovery very differently
-
BusinessHDL drug class struggling after latest flop
The failure of another ‘good’ cholesterol-raising drug and a new genetic study casts shadow over HDL hypothesis
-
NewsVoluntary controls on antibiotics on US farms criticised
The US Food and Drug Administration has introduced guidelines to try to cut antibiotic use in livestock
-
Feature
Making light work
Could light prove to be the ultimate weapon in the battle against deadly superbugs?
-
-
PodcastNitroglycerine
Peter Wothers investigates a medicinal compound with a very explosive beginning
-
-
-
PodcastTetracycline
Simon Cotton travels back to 1945 where a sample of Missouri soil produced a golden yellow antibiotic
-
Feature
The birth of the pill
Fifty years after its birth, John Mann reports on the conception and evolution of the contraceptive pill
-
PodcastVancomycin
Simon Cotton explains the chemistry behind vancomycin, an antibiotic used to treat a number of bacterial infections
-
-
CareersA cross-discipline MSc in cancer chemistry
A unique MSc course focuses on the cross-disciplinary know-how needed for a career in anti-cancer drug development. Joe McEntee reports